Bristol-Myers Squibb

Are These Diabetes Drugs Safe After All?
Motley Fool
Thu, 08/1/13 - 09:17 am
Januvia
Merck
Byetta
Bristol-Myers Squibb
diabetes
type 2 diabetes
2 Keys to Success for This Diabetes Drug's Second Chance
Motley Fool
Tue, 07/30/13 - 11:35 am
diabetes
AstraZeneca
Bristol-Myers Squibb
Forxiga
Bristol-Myers Squibb and Samsung BioLogics Announce Biopharmaceutical Manufacturing Relationship
Yahoo
Mon, 07/29/13 - 10:46 am
Bristol-Myers Squibb
Samsung BioLogics
drug manufacturing
[vid] Better Dividend: Pfizer vs. Bristol-Myers Squibb
Motley Fool
Sat, 07/27/13 - 11:22 am
Pfizer
Bristol-Myers Squibb
Diabetes Drugs’ Pancreas Risk Not Backed by Evidence: EMA
Bloomberg
Fri, 07/26/13 - 09:03 am
diabetes
Europe
Byetta
Bristol-Myers Squibb
Merck
Januvia
GLP-1 agonist
Novo Nordisk
Victoza
AstraZeneca, Bristol resubmit NDA for diabetes therapy dapagliflozin
Fierce Biotech
Thu, 07/25/13 - 11:16 am
diabetes
Dapagliflozin
Bristol-Myers Squibb
AstraZeneca
Bristol-Meyers profit falls, lowers 2013 EPS range
Marketwatch
Thu, 07/25/13 - 09:50 am
earnings
Bristol-Myers Squibb
Former Bristol-Myers Exec Settles Insider-Trading Charges for $324,777
Motley Fool
Wed, 07/24/13 - 10:46 am
insider trading
Bristol-Myers Squibb
The Diabetes Pipeline With a Clog
Motley Fool
Mon, 07/22/13 - 06:02 pm
diabetes
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
JNJ
SGLT2 inhibitor
Forxiga
Invokana
empagliflozin
Bristol-Myers Squibb Earnings Up Next
Motley Fool
Mon, 07/22/13 - 10:18 am
earnings
Bristol-Myers Squibb
Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Sat, 07/20/13 - 11:26 am
Gilead Sciences
AbbVie
hepatitis
hepatitis C
Bristol-Myers Squibb
Idenix
Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Fri, 07/19/13 - 11:38 am
hepatitis C
AbbVie
Bristol-Myers Squibb
Gilead
Idenix
sofosbuvir
ledipasvir
daclatasvir
asunaprevir
BMS-791325
IDX20963
BMY/Pfizer Seek to Expand Eliquis Label
Yahoo/Zacks
Sat, 07/13/13 - 12:09 pm
Eliquis
Bristol-Myers Squibb
Pfizer
deep vein thrombosis
Vical's Allovectin Phase 3 Trial Results: Consider The Possibilities
Seeking Alpha
Tue, 07/9/13 - 07:45 am
Viacl
Allovectin
Merck
Roche
Amgen
Bristol-Myers Squibb
Chinese Trial Misconduct Delayed Bristol-Myers Medicine
Bloomberg
Tue, 07/9/13 - 07:44 am
China
Bristol-Myers Squibb
Pfizer
Eliquis
Merck: Implications Of Capital Allocation
Seeking Alpha
Wed, 07/3/13 - 11:07 am
Bristol-Myers Squibb
Eli Lilly
AstraZeneca
Merck
capital allocation
Amgen vs. Big Pharma: It's Amgen for the Long Term
Motley Fool
Mon, 07/1/13 - 12:40 pm
Amgen
Big Pharma
Merck
Bristol-Myers Squibb
Bristol-Myers Squibb: Valuation Dependent On Pipeline
Seeking Alpha
Mon, 07/1/13 - 12:31 pm
Bristol-Myers Squibb
AstraZeneca
Pfizer’s Eliquis Stops Blood Clots as Well as Standard
Bloomberg
Mon, 07/1/13 - 11:51 am
Pfizer
Eliquis
blood clots
Bristol-Myers Squibb
Warfarin
If You Are an Income Investor, You Will Love These Pharma Companies
Motley Fool
Sun, 06/30/13 - 10:50 am
GSK
Bristol-Myers Squibb
Merck

Pages